- Home
- EXTR vs ALVO Comparison
EXTR vs ALVO Comparison
Compare EXTR & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXTR
- ALVO
- Stock Information
- Founded
- EXTR 1996
- ALVO 2013
- Country
- EXTR United States
- ALVO Luxembourg
- Employees
- EXTR N/A
- ALVO N/A
- Industry
- EXTR Telecommunications Equipment
- ALVO Biotechnology: Pharmaceutical Preparations
- Sector
- EXTR Telecommunications
- ALVO Health Care
- Exchange
- EXTR Nasdaq
- ALVO Nasdaq
- Market Cap
- EXTR 2.6B
- ALVO 2.5B
- IPO Year
- EXTR 1999
- ALVO N/A
- Fundamental
- Price
- EXTR $20.67
- ALVO $8.45
- Analyst Decision
- EXTR Strong Buy
- ALVO
- Analyst Count
- EXTR 6
- ALVO 0
- Target Price
- EXTR $21.42
- ALVO N/A
- AVG Volume (30 Days)
- EXTR 1.4M
- ALVO 457.5K
- Earning Date
- EXTR 08-06-2025
- ALVO 08-13-2025
- Dividend Yield
- EXTR N/A
- ALVO N/A
- EPS Growth
- EXTR N/A
- ALVO N/A
- EPS
- EXTR N/A
- ALVO 0.22
- Revenue
- EXTR $1,140,067,000.00
- ALVO $562,478,000.00
- Revenue This Year
- EXTR $10.26
- ALVO $36.67
- Revenue Next Year
- EXTR $7.48
- ALVO $42.58
- P/E Ratio
- EXTR N/A
- ALVO $38.85
- Revenue Growth
- EXTR 2.05
- ALVO 82.19
- 52 Week Low
- EXTR $10.10
- ALVO $7.35
- 52 Week High
- EXTR $21.35
- ALVO $13.70
- Technical
- Relative Strength Index (RSI)
- EXTR 67.59
- ALVO 45.85
- Support Level
- EXTR $19.43
- ALVO $8.15
- Resistance Level
- EXTR $20.29
- ALVO $9.06
- Average True Range (ATR)
- EXTR 0.84
- ALVO 0.38
- MACD
- EXTR 0.02
- ALVO -0.01
- Stochastic Oscillator
- EXTR 82.65
- ALVO 50.00
About EXTR Extreme Networks Inc.
Extreme Networks Inc provides AI-powered cloud networking, focused on delivering simple and secure solutions that help businesses address challenges and enable connections among devices, applications, and users. The group designs, develops, and manufactures wired, wireless, and software-defined wide area network (SD-WAN) infrastructure equipment. It has one reportable segment, the development, marketing, and sale of network infrastructure equipment and related software. The Company operates in three geographical areas: Americas, EMEA, and APAC.
About ALVO Alvotech
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases.